Skip to main content

MAP - 5 (50 mg)

This page contains information on MAP - 5 (50 mg) for veterinary use.
The information provided typically includes the following:
  • MAP - 5 (50 mg) Indications
  • Warnings and cautions for MAP - 5 (50 mg)
  • Direction and dosage information for MAP - 5 (50 mg)

MAP - 5 (50 mg)

This treatment applies to the following species:
Company: Vetoquinol USA

Sterile Sodium Hyaluronate Cryopreservative (5 mg/mL)

Each vial contains: sodium hyaluronate 50.0 mg, sodium chloride USP 85.0 mg, sodium phosphate monobasic dihydrate 0.5 mg, sodium phosphate dibasic dodecahydrate 6.0 mg, water for injection USP q.s. 10 mL. Contains no preservatives. Store at 10-30°C. Veterinary Use Only.

Vetoquinol N.-A. Inc., Lavaltrie, QC, Canada

Vetoquinol USA, Inc., Fort Worth, TX, USA

10 mL

439263 3

CPN: 1005111.1

VETOQUINOL USA, INC.
4250 N. SYLVANIA AVENUE, FORT WORTH, TX, 76137
Customer Service:   800-267-5707
Website:   www.vetoquinolusa.com
Email:   info@vetoquinolusa.com
This service and data are provided "AS IS". DVMetrics and Drugs.com assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and Drugs.com services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29